Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Brown, Julie ^a   Lethaby, Anne ^a   Maxwell, Heather ^b   Wawrzyniak, Andrew J ^c   Prins, Martin H ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Arteriosclerosis *surgery ; Graft occlusion, vascular *prevention control ; Intermittent claudication surgery ; Peripheral vascular diseases *surgery ; Platelet aggregation inhibitors *therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; COUMARIN; DIPYRIDAMOLE; INDOBUFEN; LOW MOLECULAR WEIGHT HEPARIN; NAFTIDROFURYL; PENTOXIFYLLINE; PLACEBO; PROSTAGLANDIN E1; TICLOPIDINE;

ARTERY BYPASS; ARTERY DISEASE; ATHEROSCLEROSIS; BLEEDING; CLINICAL TRIAL; DRUG FATALITY; GASTROINTESTINAL SYMPTOM; HUMAN; LIMB SALVAGE; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS;

EID: 55049130542     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000535.pub2     Document Type: Review

References (54)

1. Becquemin 1997 {published data only} Becquemin J-P. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. New England Journal of Medicine 1997;337(24):1726-31.
2. BOA 2000 {published data only} Dutch Bypass Oral anticoagulants of Aspirin (BOA) Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 2000;355(9201):346-51.
3. Clyne 1987 {published data only} Clyne CA, Archer TJ, Atuhaire LK, Chant ADB, Webster JHH. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts. British Journal of Surgery 1987;74(4):246-8.
4. D' Addato 1992 {published data only} D'Addato M, Curti T, Bertini D, Donini I, Ferrero R, Fiorani P, et al.Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass. International Angiology 1992;11(2):106-12.
5. Donaldson 1985 {published data only} Donaldson DR, Salter MCP, Kester RC, Rajah SM, Hall TJ, Sreeharan N, et al.The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. Vascular Surgery 1985;19(4):224-30.
6. Edmondson 1994 {published data only} Edmondson RA, Cohen AT, Das SK, Wagner BM, Kakkar VV. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet 1994;344(8927):914-8.
7. Goldman 1984 {published data only} Goldman M, McCollum C. A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts. Vascular Surgery 1984;18(4):217-21.
8. Green 1982 {published data only} * Green RM, Roedersheimer RL, DeWeese JA. Effects of aspirin and dipyridamole on expanded polytetrafluoethylene graft patency. Surgery 1982;92(6):1016-26.
9. Gruss 1991 {published data only} Gruss JD, Hiemer W, Kroiss A, Geissler C. Experiences with adjuvant prostaglandin therapy in vascular surgery interventions. Vasa-Supplementum 1991;33:353-54.
10. Kohler 1984 {published data only} Kohler TR, Kaufman JL, Kacoyanis G, Clowes A, Donaldson MC, Kelly E, et al.Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 1984;96(3):462-6.
11. Lucas 1984 {published data only} Lucas MA. Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs conventional antiaggregants: a six-month randomized follow-up study. Angiology 1984;35(7):443-50.
12. McCollum 1991 {published data only} McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh R. Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial. Journal of Vascular Surgery 1991;13(1):150-62.
13. Noppeney 1988 {published data only} Noppeney T, Kasprzak P, Raithel D, Hirche H. Naftidrofuryl in postoperative treatment after femoropopliteal bypass. Die Medizinische Welt 1988;39:1545-1550.
14. Raithel 1987 {published data only} Raithel D. Prevention of reocclusion after prosthetic bypass operations in the femoro-popliteal region: a comparative study of pentoxifylline versus acetylsalicylic acid. Vascular Surgery 1987;21(3):208-14.
15. Schneider 1979 {published data only} Schneider E, Brunner U, Bollinger A. No english title available [Medikamentose Rezidivprophylaxe nach femoro-poplitealer Arterienrekonstruktion]. Angio 1979;2(1):73-7.
16. Ariesen 2005 {published data only} Ariesen MJ, Tangelder MJD, Lawson JA, Elkelboom BC, Grobbee DE, Algra A. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: Therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) study. European Journal of Vascular and Endovascular Surgery 2005;30:154-9.
17. Böhmig 1995 {published data only} Böhmig HJ, Zeidler G, Schwierz TH, Loy E. Orthograde vein bypass procedure for inguinal arterial reconstructions - 20 years experience [20 Jahre orthograder Venen-Bypass für infrainguinale arterielle Rekonstruktion]. Chirurg 1995;66(2):120-6.
18. DeWeese 1971 {published data only} DeWeese JA, Rob CG. Autogenous venous bypass grafts five years later. Annals of Surgery 1971;174(3):346-56.
19. Ehersmann 1977 {published data only} Ehresmann U, Alemany J, Loew D. Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double blind long termstudy [Prophylaxe von Rezidivverschlüssen nach Revaskularisationseingriffen mit Acetylsalicylsäure]. Medizinische Welt 1977;28(26):1157-62.
20. Franks 1991 {published data only} Franks PJ, Sian M, Kenchington GF, Alexander CE, Powell JT. Aspirin usage and its influence on femoropopliteal vein graft patency. European Society for Vascular Surgery 5th Annual Meeting, 25-27 September 1991. Warsaw, Poland, 1991.
21. Gorter 2001 {published data only} Gorter JW, Oostenbrink JB, Tangelder MJ, Stroke Pi, Reversible Ischemia Trial (SPIRIT) Study Group, Dutch Bypass O, Anticoagulants or Aspirin Study(BOA). Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease. Thrombosis and Haemostasis 2001;85(1):52-56.
22. Harjola 1981 {published data only} Harjola PT, Meurala H, Frick MH. Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. Journal of Cardiovascular Surgery 1981;22(2):141-4.
23. Jivegard 2005 {published data only} Jivegard L, Drott C, Gelin J, Groth O, Hensater M, Jensen N, et al.Effects of three months of low molecular weight heparin (Dalteparin) treatment after bypass surgery for lower limb ischemia - A randomised placebo-controlled double blind multicentre trial. European Journal of Vascular and Endovascular Surgery 2005;29(2):190-8.
24. Johnson 2002 {published data only} Johnson WC, Williford WO, Department of Veterans Affairs Cooperative, Study #. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. Journal of Vascular Surgery 2002;35(3):413-21.
25. Johnson 2004 {published data only} Johnson WC, Williford WO, Corson JD, Padberg FT Jr. Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery. Vascular 2004;12(6):362-8.
26. Kibbe 2002 {published data only} Kibbe MR, Hassett AL, McSherry F, Conner P, Bontempo FA, Williford W, et al.Can screening for genetic markers improve peripheral artery bypass patency?. Journal of Vascular Surgery 2002;36(6):1198-206.
27. Lassila 1991 {published data only} Lassila R, Lepäntalo M, Lindfors O. The effect of acetylicsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking. World Journal of Surgery 1991;15(3):378-82.
28. Nevelsteen 1991 {published data only} Nevelsteen A, Mortelmans L, van de Cruys A, Merckx E, Verhaeghe R. Effect of ticlopidine on blood loss, platelet turnover and platelet deposition on prosthetic surfaces in patients undergoing aorto-femoral bypass grafting. Thrombosis Research 1991;64(3):363-9.
29. Oostenbrink 2001 {published data only} Oostenbrink JB, Tangelder MJ, Busschbach JJ, van Hout BA, Buskens E, Algra A, et al.Cost effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. Journal of Vascular Surgery 2001;34(2):254-62.
30. Powell 1992 {published data only} Powell JT, Greenhalgh RM. Smoking and factors influencing the outcome of arterial reconstruction. Annales Chirurgiae et Gynaecologiae 1992;81(2):236-41.
31. Raithel 1987 b {published data only} Raithel D, Noppeney T, Kasprzak P. [Medikamentöse Therapie nach femoro.poplitealem Kunststoffbypass - naftidrofuryl versus ASS]. Vasa-Supplementum. 1987; Vol. 20:223-Abstract No 78.
32. Reichle 1979 {published data only} Reichle FA, Rankin KP, Tyson RR, Finestone AJ, Shuman C. Long-term results of 474 arterial reconstructions for severly ischemic limbs: A fourteen year follow-up. Surgery 1979;85(1):93-100.
33. Rosenthal 1987 {published data only} Rosenthal D, Mittenthal MH, Ruben DM, Jones DH, Estes JW, Stanton PE, et al.The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: Long-term results. American Surgeon 1987;53(9):477-81.
34. Satiani 1985 {published data only} Satiani B. A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts. Angiology 1985;36(9):608-16.
35. Shionoya 1990 {published data only} Shionoya S, Sakurai T, Ueyama T, Kusakawa M, Sakaguchi S, Tsuchioka H, et al.Effect of ticlopidine on graft patency following arterial reconstructive surgery in the lower extremity: a multicenter three-year prospective study. Vascular Surgery 1990;24(8):541-7.
36. Smeets 2005 {published data only} Smeets L, Ho GH, Tangelder MJ, Algra A, Lawson JA, Eikelboom BC, Moll FL, Dutch BOA Study Group. Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts. European Journal of Vascular and Endovascular Surgery 2005;30(6):604-609.
37. Smout 2004 {published data only} Smout JD, Mikhailidis DP, Shenton BK, Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. Clinical and Applied Thrombosis/ Hemostasis 2004;10(1):9-18. [MEDLINE: 6304]
38. Tangelder 1995 {published data only} Tangelder MJD, Eikelboom BC, Lawson JA, Algra A. Preventi van occlusies na perifere bypass-chirurgie met orale anticoagulantia of acetylsalicylzuur: een gerandomiseerde vergelijking in het Nederlands BOA-onderzoek. Nederlands Tijdschrift voor Geneeskunde 1995;139(29):1504-6.
39. Tangelder 1999 {published data only} Tangelder MJ, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC. Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. Journal of Vascular Surgery 1999;29(5):913-9.
40. Tangelder 2000a {published data only} Tangelder MJ, Algra A, Lawson JA, Eikelboom BC. Risk factors for occlusion of infrainguinal bypass grafts. European Journal of Vascular and Endovascular Surgery 2000;20(2):118-24. [MEDLINE: 4716]
41. Tangelder 2001 {published data only} Tangelder MJ, Algra A, Lawson JA, Hennekes S, Eikelboom BC. Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group. Journal of Vascular Surgery 2001;33(3):522-7.
42. Abbott 1997 Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, et al.Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. Journal of Vascular Surgery 1997;25(1):19-28.
43. Altman 1999 Altman R, Scazziota A, Rouvier J, Gonzalez C. Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity. Clinical and Applied Thrombosis/Hemostasis 1999;5(4): 243-6.
44. Bertrand 2000 Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102(6):624-9.
45. Consensus 1991 European Working Group on Critical Limb Ischemia. Second European Consensus Document on Chronic Critical Leg Ischemia. Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation 1991;84 Suppl 4:1-26.
46. Cooper 1990 Cooper GG, Austin C, Fitzsimmons E, Brannigan PD, Hood JM, D'Sa AA. Outflow resistance and early occlusion of infrainguinal bypass grafts. European Journal of Vascular Surgery 1990;4(3):279-83.
47. Fujitani 1988 Fujitani RM, Nordestgaard AG, Marcus CS, Wilson SE. Perioperative suppression of platelet adherence to small-diameter polytetrafluoroethylene (PTFE) grafts. Journal of Surgical Research 1988;44(4):455-60.
48. Mishkel 1999 Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. Journal of the American College of Cardiology 1999;34(7):1884-90.
49. Moshfegh 2000 Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, et al.Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. Journal of the American College of Cardiology 2000;36(3):699-705.
50. Muluk 1998 Muluk SC, Vorp DA, Severyn DA, Gleixner S, Johnson PC, Webster MW. Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamics. Journal of Vascular Surgery 1998;27(3):521-7.
51. Nielsen 1997 Nielsen TG, Hesse B, Eiberg J, Rabol A, Folke M, Schroeder TV. Scintigraphic assessment of focal platelet accumulations following infrainguinal bypass surgery in humans. Clinical Physiology 1997;17(6):545-55.
52. Rutherford 1988 Rutherford RB, Jones DN, Bergentz SE, Bergqvist D, Comerota AJ, Dardik H, et al.Factors affecting the patency of infrainguinal bypass. Journal of Vascular Surgery 1988;8(3):236-46.
53. Tangelder 2000 Tangelder MJ, Algra A, Lawson JA, Eikelboom, BC. Risk factors for occlusion of infrainguinal bypass grafts. European Journal of Vascular and Endovascular Surgery 2000;20(2):118-24.
54. Cochrane 2003 J Dörffler-Melly, HR Büller, MM Koopman, MH Prins. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD000535]